100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Grant Awards
Project Grant R41GM136037
Award Date
2/7/20
Completion Date
8/6/21
Dollars Obligated
$225K
Overview
Activity
3
Transactions
3
Subawards
Similar Awards
Federal Agency
National Institute of General Medical Sciences
Awardee
Scribe Biosciences, Inc. (QMCJSMLF9TP1)
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
California, USA
Update #1
Update #2
A PLATFORM FOR ENGINEERING PEPTIDE LIGASE FOR BUILDING NEXT GENERATION PEPTIDE THERAPEUTICS.
Posted 2/7/20
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
Not listed
A PLATFORM FOR ENGINEERING PEPTIDE LIGASE FOR BUILDING NEXT GENERATION PEPTIDE THERAPEUTICS. - PROJECT SUMMARY THERE IS AN INCREASED INTEREST IN PEPTIDE MEDICINES IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT (R & D) BECAUSE PEPTIDES ARE RECOGNIZED AS HIGHLY SELECTIVE AND EFFICACIOUS, AND AT THE SAME TIME RELATIVELY SAFE AND WELL TOLERATED. CHEMO-ENZYMATIC PEPTIDE SYNTHESIS (CEPS) USING PEPTIDE LIGASES FEATURES EXCELLENT PURITY AND YIELD, THUS BECOMING AN ATTRACTIVE METHOD TO REPLACE TRADITIONAL CHEMICAL SYNTHESIS METHOD FOR SYNTHESIZING PEPTIDE DRUGS. HOWEVER, THE DEVELOPMENT OF EFFICIENT AND VERSATILE PEPTIDE LIGASES LAGS BEHIND, LIMITING THE ADVANCEMENT OF PEPTIDE THERAPEUTICS. FUNDAMENTALLY, THIS IS DUE TO THE INEFFICIENCY OF CURRENT PEPTIDE LIGASE ENGINEERING METHOD THAT RELIES ON RATIONAL PROTEIN ENGINEERING COUPLED WITH LOW THROUGHPUT ENZYMATIC CHARACTERIZATION. WE WILL OVERCOME THIS LIMITATION BY DEVELOPING A SPECIALIZED MICROFLUIDIC SYSTEM FOR HIGH THROUGHPUT PEPTIDE LIGASE ENGINEERING. WE WILL MERGE MODERN BIOCHEMISTRY AND MOLECULAR BIOLOGY METHODS WITH ADVANCED DROPLET MICROFLUIDICS TO ENABLE HIGH THROUGHPUT SCREENING OF PEPTIDE LIGASE VARIANTS. IN THIS PROJECT, WE WILL BUILD AN ENZYME SCREENING PLATFORM AND DEMONSTRATE ITS CAPACITY ON INCREASING AMINOLYSIS TO HYDROLYSIS RATIO OF SUBTILIGASE (A WELL CHARACTERIZED PEPTIDE LIGASE). IN SPECIFIC AIM 1, WE WILL DEVELOP A MICROFLUIDIC SYSTEM FOR ULTRAHIGH-THROUGHPUT AND QUANTITATIVE ANALYSIS OF SUBTILIGASES. WE WILL DEVELOP THE MICROFLUIDIC HARDWARE, PROCESSES, AND ASSAYS TO ENABLE THE ANALYSIS AND SCREENING OF A LARGE NUMBER (OVER 106) OF VARIANTS OF SUBTILIGASE. IN SPECIFIC AIM 2, WE WILL ESTABLISH AND TEST SUBTILIGASE SCREENING PLATFORM. WE WILL DESIGN AND SYNTHESIZE SUBTILIGASE VARIANT LIBRARY AND WE WILL DEMONSTRATE THE THROUGHPUT AND SENSITIVITY OF OUR MICROFLUIDIC SYSTEM USING A MOCK SUBTILIGASE VARIANT LIBRARY. WE WILL ALSO ESTABLISH KINETIC ASSAYS FOR CHARACTERING SUBTILIGASE. ACHIEVING THESE AIMS WILL PROVE THAT PEPTIDE LIGASE ASSAY WITH HIGH SENSITIVITY CAN BE INCORPORATED WITH DROPLET MICROFLUIDIC COMPONENTS TO ENABLE HIGH THROUGHPUT ENGINEERING OF PEPTIDE LIGASE. A PROPOSED PHASE II PROJECT WOULD INVOLVE SCREENING OF SUBTILIGASE LIBRARIES TO INCREASE AMINOLYSIS TO HYDROLYSIS RATIO OF SUBTILIGASE AND APPLYING OUR ENGINEERING SYSTEM TO ENGINEER OTHER IMPORTANT PROPERTIES OF PEPTIDE LIGASES SUCH AS SUBSTRATE SELECTIVITY AND RACEMIZATION ACTIVITY AS WELL AS EARLY PRODUCTION OF HARDWARE AND DISPOSABLES.
$0
3/15/22
Not listed
A PLATFORM FOR ENGINEERING PEPTIDE LIGASE FOR BUILDING NEXT GENERATION PEPTIDE THERAPEUTICS. - PROJECT SUMMARY THERE IS AN INCREASED INTEREST IN PEPTIDE MEDICINES IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT (R & D) BECAUSE PEPTIDES ARE RECOGNIZED AS HIGHLY SELECTIVE AND EFFICACIOUS, AND AT THE SAME TIME RELATIVELY SAFE AND WELL TOLERATED. CHEMO-ENZYMATIC PEPTIDE SYNTHESIS (CEPS) USING PEPTIDE LIGASES FEATURES EXCELLENT PURITY AND YIELD, THUS BECOMING AN ATTRACTIVE METHOD TO REPLACE TRADITIONAL CHEMICAL SYNTHESIS METHOD FOR SYNTHESIZING PEPTIDE DRUGS. HOWEVER, THE DEVELOPMENT OF EFFICIENT AND VERSATILE PEPTIDE LIGASES LAGS BEHIND, LIMITING THE ADVANCEMENT OF PEPTIDE THERAPEUTICS. FUNDAMENTALLY, THIS IS DUE TO THE INEFFICIENCY OF CURRENT PEPTIDE LIGASE ENGINEERING METHOD THAT RELIES ON RATIONAL PROTEIN ENGINEERING COUPLED WITH LOW THROUGHPUT ENZYMATIC CHARACTERIZATION. WE WILL OVERCOME THIS LIMITATION BY DEVELOPING A SPECIALIZED MICROFLUIDIC SYSTEM FOR HIGH THROUGHPUT PEPTIDE LIGASE ENGINEERING. WE WILL MERGE MODERN BIOCHEMISTRY AND MOLECULAR BIOLOGY METHODS WITH ADVANCED DROPLET MICROFLUIDICS TO ENABLE HIGH THROUGHPUT SCREENING OF PEPTIDE LIGASE VARIANTS. IN THIS PROJECT, WE WILL BUILD AN ENZYME SCREENING PLATFORM AND DEMONSTRATE ITS CAPACITY ON INCREASING AMINOLYSIS TO HYDROLYSIS RATIO OF SUBTILIGASE (A WELL CHARACTERIZED PEPTIDE LIGASE). IN SPECIFIC AIM 1, WE WILL DEVELOP A MICROFLUIDIC SYSTEM FOR ULTRAHIGH-THROUGHPUT AND QUANTITATIVE ANALYSIS OF SUBTILIGASES. WE WILL DEVELOP THE MICROFLUIDIC HARDWARE, PROCESSES, AND ASSAYS TO ENABLE THE ANALYSIS AND SCREENING OF A LARGE NUMBER (OVER 106) OF VARIANTS OF SUBTILIGASE. IN SPECIFIC AIM 2, WE WILL ESTABLISH AND TEST SUBTILIGASE SCREENING PLATFORM. WE WILL DESIGN AND SYNTHESIZE SUBTILIGASE VARIANT LIBRARY AND WE WILL DEMONSTRATE THE THROUGHPUT AND SENSITIVITY OF OUR MICROFLUIDIC SYSTEM USING A MOCK SUBTILIGASE VARIANT LIBRARY. WE WILL ALSO ESTABLISH KINETIC ASSAYS FOR CHARACTERING SUBTILIGASE. ACHIEVING THESE AIMS WILL PROVE THAT PEPTIDE LIGASE ASSAY WITH HIGH SENSITIVITY CAN BE INCORPORATED WITH DROPLET MICROFLUIDIC COMPONENTS TO ENABLE HIGH THROUGHPUT ENGINEERING OF PEPTIDE LIGASE. A PROPOSED PHASE II PROJECT WOULD INVOLVE SCREENING OF SUBTILIGASE LIBRARIES TO INCREASE AMINOLYSIS TO HYDROLYSIS RATIO OF SUBTILIGASE AND APPLYING OUR ENGINEERING SYSTEM TO ENGINEER OTHER IMPORTANT PROPERTIES OF PEPTIDE LIGASES SUCH AS SUBSTRATE SELECTIVITY AND RACEMIZATION ACTIVITY AS WELL AS EARLY PRODUCTION OF HARDWARE AND DISPOSABLES.
$0
3/15/22
Not listed
A PLATFORM FOR ENGINEERING PEPTIDE LIGASE FOR BUILDING NEXT GENERATION PEPTIDE THERAPEUTICS.
$225.0k
2/7/20